"Together Phoebe Rich Dermatology with the Oregon Dermatology & Research Center provides expert care to patients in NW Portland, specializing in nail disease and new treatments as part of clinical trials. Our providers are attentive to our patients needs and ensure individuals receive the best quality of care. Our clinic offers a wide variety of dermatologic care including, but not limited to, annual skin examinations, treatment of precancerous and cancerous skin conditions, acne, warts, eczema, psoriasis, nail diseases and disorders, and nail biopsies. Our providers are highly trained and are informative and conscious about the care and treatment patients receive."

During the past decade, Oregon Dermatology and Research Center conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 35 clinical trials were completed, i.e. on average, 97.2% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 20 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oregon Dermatology and Research Center" #1 sponsor was "Eli Lilly and Company" with 11 trials, followed by "Galderma R&D" with 7 trials sponsored, "Janssen Research & Development, LLC" with 5 trials sponsored, "Pfizer" with 5 trials sponsored and "Dow Pharmaceutical Sciences" with 5 trials sponsored. Other sponsors include 31 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oregon Dermatology and Research Center" #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "Dermira, Inc." with 2 trials as a collaborator, "GlaxoSmithKline" with 2 trials as a collaborator, "AmDerma Pharmaceuticals, LLC" with 1 trials as a collaborator and "Basilea Pharmaceutica" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Oregon Dermatology and Research Center" are "Atopic Dermatitis" (10 trials), "Psoriasis" (10 trials), "Acne Vulgaris" (9 trials), "Plaque Psoriasis" (9 trials) and "Onychomycosis" (6 trials). Many other conditions were trialed in "Oregon Dermatology and Research Center" in a lesser frequency.

Most popular intervention types in "Oregon Dermatology and Research Center" are "Drug" (62 trials), "Other" (6 trials), "Biological" (5 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Baricitinib" (3 trials), "Mirikizumab" (3 trials), "Vehicle" (3 trials) and "Aminolevulinic Acid (ALA)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Oregon Dermatology and Research Center" are 67 trials for "All" genders.

Currently, there are NaN active trials in "Oregon Dermatology and Research Center". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 53 completed trials in Oregon Dermatology and Research Center, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Oregon Dermatology and Research Center, 1 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".